1H3 — Clearbridge Health Income Statement
0.000.00%
Last trade - 00:00
- SG$6.19m
- SG$12.43m
- SG$11.49m
R2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.5 | 36.3 | 11.4 | 16.4 | 11.5 |
Cost of Revenue | |||||
Gross Profit | 7.16 | 13.8 | 6.36 | 9.58 | 6.09 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 31.3 | 31.8 | 23.3 | 26.8 | 45.1 |
Operating Profit | -9.74 | 4.45 | -11.8 | -10.4 | -33.6 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -11.7 | 2.12 | -13.6 | -11.2 | -34.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11.7 | 2.07 | -13.9 | -11.4 | -32.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -10.6 | 0.615 | -20 | -11.1 | -32.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.6 | 0.615 | -20 | -11.1 | -32.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.017 | 0.001 | -0.03 | -0.02 | -0.041 |